Glp-1 Analogs And Postprandial Eating Behavior

Elucidating the relationship between GLP-1 analogs and ingestive behavior could reveal additional parameters which contribute to their anti-obesity effects.

These results suggest that postprandial increases in GLP-1 may play an indirect role in regulating eating behaviors through preferential striatal responsivity to low-calorie (healthier) foods.

The results presented in this review highlight the potential of nutritional and physiologic stimulation of GLP-1 secretion. Further research on fasting and postprandial GLP-1 concentrations and the resulting metabolic consequences under different metabolic conditions is needed.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used to improve glycemic control and induce weight loss in individuals with type 2 diabetes (T2D), yet treatment responses vary significantly among individuals. Eating behavior has been hypothesized to influence therapeutic efficacy, but supporting evidence remains limited. Methods:

Here we provide a targeted synthesis of recent developments in the field of GLP-1 neurobiology, highlighting studies which have advanced our understanding of how GLP-1 signaling modulates eating, and identify open questions and future challenges we believe still need to be addressed to aid the prevention and/or treatment of obesity.

Key Takeaways. GLP-1s may reduce overall food intake, making nutrient-dense choices more important when planning grocery purchases. Eating enough fruits and vegetables should come before deciding whether organic produce is worth the added cost.